CytomX Therapeutics Stock (NASDAQ: CTMX) stock price, news, charts, stock research, profile.
You can purchase shares of CytomX Therapeutics (NASDAQ:CTMX) through any online brokerage.
Other companies in CytomX Therapeutics’s space includes: bluebird bio (NASDAQ:BLUE), Cellectar Biosciences (NASDAQ:CLRB), Immuneering (NASDAQ:IMRX), Aligos Therapeutics (NASDAQ:ALGS) and Armata Pharmaceuticals (AMEX:ARMP).
CytomX Therapeutics has a consensus price target of $6.29.
The stock price for CytomX Therapeutics (NASDAQ: CTMX) is $0.885 last updated November 21, 2024 at 7:12 PM EST.
There are no upcoming dividends for CytomX Therapeutics.
CytomX Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for CytomX Therapeutics.
CytomX Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.